<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01067781</url>
  </required_header>
  <id_info>
    <org_study_id>ELT208</org_study_id>
    <nct_id>NCT01067781</nct_id>
  </id_info>
  <brief_title>Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch</brief_title>
  <official_title>A Phase 2, Gender-Stratified, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Two Vaccination Regimen With the Travelers' Diarrhea Vaccine System in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intercell USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intercell USA, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and compare the safety and immune responses
      following a two vaccination regimen by transcutaneous immunization with heat-labile
      enterotoxin of E. coli (LT) patches or Placebo, with or without alcohol swabbing
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Characterization and Comparison of the Safety of the TD Vaccine System: (1) Solicited and Unsolicited Adverse Events (AEs) (2) Clinical Laboratory Safety (3) Serious AEs</measure>
    <time_frame>Day 0 to Day 180</time_frame>
    <description>Erythema, rash, pain, pruritus, hyperpigmentation, hypopigmentation and edema were solicited local AEs for the duration of the study. Fever, malaise, headache, and diarrhea were solicited systemic AEs for the first seven days following each vaccination; events reported outside this time frame were considered non-solicited.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Geometric Mean Titers</measure>
    <time_frame>Day 0 to Day 180</time_frame>
    <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Geometric Mean Fold Ratios</measure>
    <time_frame>Day 0 to Day 180</time_frame>
    <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Seroconversion Rates</measure>
    <time_frame>Day 0 to Day 180</time_frame>
    <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Diarrhea</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two vaccination regimen with an LT patch (no swabbing)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two vaccination regimen with an LT patch (with swabbing)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two vaccination regimen with a placebo patch (no swabbing)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two vaccination regimen with a placebo patch (with swabbing)</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Heat-Labile Enterotoxin of E. coli (LT)</intervention_name>
    <description>Travelers' Diarrhea Vaccine System</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Travelers' Diarrhea Vaccine System</description>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. A female or male 18-64 (inclusive) years of age;

          2. In good health as determined by medical history and screening exam;

          3. Females who are post-menopausal, surgically sterile, or have a negative serum/urine
             pregnancy test at Day 0 and agree not to become pregnant for the duration of study.

        Exclusion Criteria:

          1. Abnormalities at physical exam [as determined by the Toxicity Grading Scale (Grade
             1-4)];

          2. Laboratory abnormalities [as determined by the Toxicity Grading Scale (Grade 1 4)] at
             screening;

          3. Participated in research involving investigational product within 30 days before
             planned date of first vaccination;

          4. Ever received investigational enterotoxigenic E. coli, LT, or LT (R192G) or NasalFlu,
             Berna Biotech, Ltd;

          5. Women who are pregnant or breastfeeding;

          6. Clinically significant underlying enteric, pulmonary, cardiac or renal disease;

          7. Current seizure disorder;

          8. Current use of immunosuppressive therapy (inhaled steroids are allowed);

          9. Known or suspected alcohol abuse or illicit drug use within the last year;

         10. Positive Serology for HIV-1, HIV-2, HbsAg, or HCV;

         11. Known allergies to any component of the vaccine including adhesives;

         12. An employee of the study site;

         13. An employee of Intercell (global) or an immediate family member;

         14. Visible tattoos or marks (tattoos/scars) at the vaccination areas that would prevent
             appropriate dermatologic monitoring of the vaccination sites;

         15. Receipt of any routine vaccinations within 7 days prior to, or following, the date of
             planned study vaccinations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Sheldon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Miami Research Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Advanced Clinical Research Institute</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Research Associates</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johnson County Clinical Trials</name>
      <address>
        <city>Lenexa</city>
        <state>Kansas</state>
        <zip>66219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Trials of Texas</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.valneva.com</url>
    <description>Intercell Home Page</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 9, 2010</study_first_submitted>
  <study_first_submitted_qc>February 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2010</study_first_posted>
  <results_first_submitted>January 30, 2014</results_first_submitted>
  <results_first_submitted_qc>January 30, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 13, 2014</results_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prevention of Travelers' Diarrhea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group 1: 37.5μg LT, No Swab</title>
          <description>Two vaccination regimen with an LT patch (no swabbing)
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="P2">
          <title>Group 2: 37.5μg LT, Swab</title>
          <description>Two vaccination regimen with an LT patch (with swabbing)
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="P3">
          <title>Group 3: 0μg LT, No Swab</title>
          <description>Two vaccination regimen with a placebo patch (no swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="P4">
          <title>Group 4: 0μg LT, Swab</title>
          <description>Two vaccination regimen with a placebo patch (with swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Up to Day 180</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="203"/>
                <participants group_id="P2" count="199"/>
                <participants group_id="P3" count="97"/>
                <participants group_id="P4" count="101"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="173"/>
                <participants group_id="P2" count="168"/>
                <participants group_id="P3" count="89"/>
                <participants group_id="P4" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="31"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>180 to Day 720</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="173"/>
                <participants group_id="P2" count="168"/>
                <participants group_id="P3" count="89"/>
                <participants group_id="P4" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3">all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)</participants>
                <participants group_id="P2" count="4">all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)</participants>
                <participants group_id="P3" count="0">all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)</participants>
                <participants group_id="P4" count="0">all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="170"/>
                <participants group_id="P2" count="164"/>
                <participants group_id="P3" count="89"/>
                <participants group_id="P4" count="89"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>safety population: includes all study subjects that were consented and received investigational study material (i.e., at least one vaccination)</population>
      <group_list>
        <group group_id="B1">
          <title>Group 1: 37.5μg LT, No Swab</title>
          <description>Two vaccination regimen with an LT patch (no swabbing)
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="B2">
          <title>Group 2: 37.5μg LT, Swab</title>
          <description>Two vaccination regimen with an LT patch (with swabbing)
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="B3">
          <title>Group 3: 0μg LT, No Swab</title>
          <description>Two vaccination regimen with a placebo patch (no swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="B4">
          <title>Group 4: 0μg LT, Swab</title>
          <description>Two vaccination regimen with a placebo patch (with swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="203"/>
            <count group_id="B2" value="199"/>
            <count group_id="B3" value="97"/>
            <count group_id="B4" value="101"/>
            <count group_id="B5" value="600"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.0" spread="12.8"/>
                    <measurement group_id="B2" value="35.3" spread="13.1"/>
                    <measurement group_id="B3" value="35.0" spread="13.6"/>
                    <measurement group_id="B4" value="35.7" spread="12.8"/>
                    <measurement group_id="B5" value="35.3" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="102"/>
                    <measurement group_id="B2" value="99"/>
                    <measurement group_id="B3" value="48"/>
                    <measurement group_id="B4" value="51"/>
                    <measurement group_id="B5" value="300"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="49"/>
                    <measurement group_id="B4" value="50"/>
                    <measurement group_id="B5" value="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Characterization and Comparison of the Safety of the TD Vaccine System: (1) Solicited and Unsolicited Adverse Events (AEs) (2) Clinical Laboratory Safety (3) Serious AEs</title>
        <description>Erythema, rash, pain, pruritus, hyperpigmentation, hypopigmentation and edema were solicited local AEs for the duration of the study. Fever, malaise, headache, and diarrhea were solicited systemic AEs for the first seven days following each vaccination; events reported outside this time frame were considered non-solicited.</description>
        <time_frame>Day 0 to Day 180</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1 &amp; 2 Combined: 37.5µg LT Patch</title>
            <description>with or without swabbing</description>
          </group>
          <group group_id="O2">
            <title>Group 3 &amp; 4 Combined: Placebo Patch (0µg LT)</title>
            <description>with or without swabbing</description>
          </group>
        </group_list>
        <measure>
          <title>Characterization and Comparison of the Safety of the TD Vaccine System: (1) Solicited and Unsolicited Adverse Events (AEs) (2) Clinical Laboratory Safety (3) Serious AEs</title>
          <description>Erythema, rash, pain, pruritus, hyperpigmentation, hypopigmentation and edema were solicited local AEs for the duration of the study. Fever, malaise, headache, and diarrhea were solicited systemic AEs for the first seven days following each vaccination; events reported outside this time frame were considered non-solicited.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="402"/>
                <count group_id="O2" value="198"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Solicited Local Adverse Events (1st vaccination)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="318"/>
                    <measurement group_id="O2" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Solicited Local AEs (2nd vaccination)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="327"/>
                    <measurement group_id="O2" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-solicited Local AEs (1st vaccination)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-solicited Local AEs (2nd vaccination)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Solicited Systemic AEs (overall)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134"/>
                    <measurement group_id="O2" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-solicited Systemic AEs (overall)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="296"/>
                    <measurement group_id="O2" value="148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Geometric Mean Titers</title>
        <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
        <time_frame>Day 0 to Day 180</time_frame>
        <population>the numbers analyzed differs from the Overall number analyzed because for this the Immunogenicity Evaluable Population (IEP) was used: includes all study subjects that were consented, randomized, received the assigned Treatments (both vaccinations) without significant protocol deviations and had blood drawn on Day 0, Day 21 and Day 35</population>
        <group_list>
          <group group_id="O1">
            <title>LT Patch Without Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with an LT patch (no swabbing), 37.5 mcg LT
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O2">
            <title>LT Patch With Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with an LT patch (with swabbing), 37.5 mcg LT
SPS:Buffer-prepared site swabbed with a 70% isopropyl alcohol pad
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O3">
            <title>Placebo Patch Without Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with a placebo patch (no swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O4">
            <title>Placebo Patch With Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with a placebo patch (with swabbing)
SPS:Buffer-prepared site swabbed with a 70% isopropyl alcohol pad
Placebo: Travelers' Diarrhea Vaccine System</description>
          </group>
        </group_list>
        <measure>
          <title>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Geometric Mean Titers</title>
          <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
          <population>the numbers analyzed differs from the Overall number analyzed because for this the Immunogenicity Evaluable Population (IEP) was used: includes all study subjects that were consented, randomized, received the assigned Treatments (both vaccinations) without significant protocol deviations and had blood drawn on Day 0, Day 21 and Day 35</population>
          <units>titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="182"/>
                <count group_id="O2" value="173"/>
                <count group_id="O3" value="92"/>
                <count group_id="O4" value="90"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IgG Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="442.21" lower_limit="386.83" upper_limit="505.53"/>
                    <measurement group_id="O2" value="421.20" lower_limit="368.78" upper_limit="481.06"/>
                    <measurement group_id="O3" value="435.64" lower_limit="360.89" upper_limit="525.89"/>
                    <measurement group_id="O4" value="344.40" lower_limit="282.43" upper_limit="419.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="455.68" lower_limit="402.07" upper_limit="516.44"/>
                    <measurement group_id="O2" value="437.80" lower_limit="380.75" upper_limit="503.39"/>
                    <measurement group_id="O3" value="426.28" lower_limit="352.98" upper_limit="514.81"/>
                    <measurement group_id="O4" value="348.13" lower_limit="289.47" upper_limit="418.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1042.41" lower_limit="862.90" upper_limit="1259.26"/>
                    <measurement group_id="O2" value="1148.98" lower_limit="940.12" upper_limit="1404.24"/>
                    <measurement group_id="O3" value="433.13" lower_limit="357.98" upper_limit="524.06"/>
                    <measurement group_id="O4" value="336.41" lower_limit="276.48" upper_limit="409.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 21</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2036.77" lower_limit="1678.75" upper_limit="2471.14"/>
                    <measurement group_id="O2" value="2537.89" lower_limit="2073.46" upper_limit="3106.35"/>
                    <measurement group_id="O3" value="447.47" lower_limit="371.36" upper_limit="539.18"/>
                    <measurement group_id="O4" value="404.66" lower_limit="332.68" upper_limit="492.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="180"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4010.55" lower_limit="3424.12" upper_limit="4697.41"/>
                    <measurement group_id="O2" value="4806.53" lower_limit="4057.60" upper_limit="5693.69"/>
                    <measurement group_id="O3" value="571.09" lower_limit="463.60" upper_limit="703.49"/>
                    <measurement group_id="O4" value="418.78" lower_limit="353.08" upper_limit="496.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4820.85" lower_limit="4121.82" upper_limit="5638.42"/>
                    <measurement group_id="O2" value="6005.34" lower_limit="5126.11" upper_limit="7035.37"/>
                    <measurement group_id="O3" value="573.03" lower_limit="471.04" upper_limit="697.12"/>
                    <measurement group_id="O4" value="421.34" lower_limit="359.37" upper_limit="494.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 42</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5229.02" lower_limit="4526.96" upper_limit="6039.96"/>
                    <measurement group_id="O2" value="5757.21" lower_limit="4949.95" upper_limit="6696.11"/>
                    <measurement group_id="O3" value="582.72" lower_limit="469.17" upper_limit="723.76"/>
                    <measurement group_id="O4" value="427.64" lower_limit="357.27" upper_limit="511.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="177"/>
                    <count group_id="O2" value="167"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5056.13" lower_limit="4380.77" upper_limit="5835.60"/>
                    <measurement group_id="O2" value="5633.07" lower_limit="4910.89" upper_limit="6461.46"/>
                    <measurement group_id="O3" value="588.69" lower_limit="484.87" upper_limit="714.74"/>
                    <measurement group_id="O4" value="411.26" lower_limit="340.90" upper_limit="496.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 90</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="161"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4833.84" lower_limit="4231.66" upper_limit="5521.71"/>
                    <measurement group_id="O2" value="4695.02" lower_limit="4085.96" upper_limit="5394.87"/>
                    <measurement group_id="O3" value="537.23" lower_limit="440.47" upper_limit="655.24"/>
                    <measurement group_id="O4" value="464.11" lower_limit="390.50" upper_limit="551.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG Day 180</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="161"/>
                    <count group_id="O2" value="154"/>
                    <count group_id="O3" value="85"/>
                    <count group_id="O4" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2809.18" lower_limit="2440.40" upper_limit="3233.67"/>
                    <measurement group_id="O2" value="2843.59" lower_limit="2486.76" upper_limit="3251.61"/>
                    <measurement group_id="O3" value="498.20" lower_limit="404.73" upper_limit="613.24"/>
                    <measurement group_id="O4" value="419.89" lower_limit="354.80" upper_limit="496.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.71" lower_limit="65.10" upper_limit="81.22"/>
                    <measurement group_id="O2" value="67.06" lower_limit="60.62" upper_limit="74.18"/>
                    <measurement group_id="O3" value="63.00" lower_limit="55.53" upper_limit="71.46"/>
                    <measurement group_id="O4" value="69.52" lower_limit="59.90" upper_limit="80.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.30" lower_limit="66.09" upper_limit="83.52"/>
                    <measurement group_id="O2" value="65.29" lower_limit="58.70" upper_limit="72.62"/>
                    <measurement group_id="O3" value="62.26" lower_limit="54.81" upper_limit="70.72"/>
                    <measurement group_id="O4" value="70.77" lower_limit="60.62" upper_limit="82.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130.89" lower_limit="112.10" upper_limit="152.83"/>
                    <measurement group_id="O2" value="132.33" lower_limit="111.62" upper_limit="156.87"/>
                    <measurement group_id="O3" value="59.70" lower_limit="53.47" upper_limit="66.67"/>
                    <measurement group_id="O4" value="69.79" lower_limit="59.78" upper_limit="81.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 21</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="183.42" lower_limit="155.55" upper_limit="216.29"/>
                    <measurement group_id="O2" value="175.05" lower_limit="147.46" upper_limit="207.79"/>
                    <measurement group_id="O3" value="65.82" lower_limit="56.12" upper_limit="77.18"/>
                    <measurement group_id="O4" value="69.91" lower_limit="59.83" upper_limit="81.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="180"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="290.95" lower_limit="251.96" upper_limit="335.99"/>
                    <measurement group_id="O2" value="294.68" lower_limit="252.19" upper_limit="344.34"/>
                    <measurement group_id="O3" value="67.52" lower_limit="57.86" upper_limit="78.79"/>
                    <measurement group_id="O4" value="76.00" lower_limit="64.41" upper_limit="89.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="284.26" lower_limit="247.37" upper_limit="326.66"/>
                    <measurement group_id="O2" value="286.88" lower_limit="245.46" upper_limit="335.29"/>
                    <measurement group_id="O3" value="69.84" lower_limit="60.23" upper_limit="80.99"/>
                    <measurement group_id="O4" value="74.91" lower_limit="63.19" upper_limit="88.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 42</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="248.33" lower_limit="214.74" upper_limit="287.17"/>
                    <measurement group_id="O2" value="261.53" lower_limit="223.84" upper_limit="305.58"/>
                    <measurement group_id="O3" value="67.45" lower_limit="58.30" upper_limit="78.03"/>
                    <measurement group_id="O4" value="71.97" lower_limit="61.24" upper_limit="84.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="177"/>
                    <count group_id="O2" value="167"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="229.76" lower_limit="198.94" upper_limit="265.34"/>
                    <measurement group_id="O2" value="232.70" lower_limit="200.49" upper_limit="270.09"/>
                    <measurement group_id="O3" value="70.11" lower_limit="59.62" upper_limit="82.44"/>
                    <measurement group_id="O4" value="78.60" lower_limit="66.30" upper_limit="93.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 90</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="161"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168.18" lower_limit="144.93" upper_limit="195.16"/>
                    <measurement group_id="O2" value="166.85" lower_limit="142.94" upper_limit="194.75"/>
                    <measurement group_id="O3" value="61.79" lower_limit="53.98" upper_limit="70.73"/>
                    <measurement group_id="O4" value="70.93" lower_limit="60.92" upper_limit="82.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgA Day 180</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="161"/>
                    <count group_id="O2" value="154"/>
                    <count group_id="O3" value="85"/>
                    <count group_id="O4" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.12" lower_limit="104.49" upper_limit="138.08"/>
                    <measurement group_id="O2" value="124.50" lower_limit="107.41" upper_limit="144.30"/>
                    <measurement group_id="O3" value="56.00" lower_limit="50.00" upper_limit="62.72"/>
                    <measurement group_id="O4" value="61.30" lower_limit="53.98" upper_limit="69.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Geometric Mean Fold Ratios</title>
        <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
        <time_frame>Day 0 to Day 180</time_frame>
        <population>the numbers analyzed differs from the Overall number analyzed because for this the Immunogenicity Evaluable Population (IEP) was used: includes all study subjects that were consented, randomized, received the assigned Treatments (both vaccinations) without significant protocol deviations and had blood drawn on Day 0, Day 21 and Day 35</population>
        <group_list>
          <group group_id="O1">
            <title>LT Patch Without Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with an LT patch (no swabbing), 37.5 mcg LT
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O2">
            <title>LT Patch With Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with an LT patch (with swabbing), 37.5 mcg LT
SPS:Buffer-prepared site swabbed with a 70% isopropyl alcohol pad
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O3">
            <title>Placebo Patch Without Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with a placebo patch (no swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O4">
            <title>Placebo Patch With Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with a placebo patch (with swabbing)
SPS:Buffer-prepared site swabbed with a 70% isopropyl alcohol pad
Placebo: Travelers' Diarrhea Vaccine System</description>
          </group>
        </group_list>
        <measure>
          <title>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Geometric Mean Fold Ratios</title>
          <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
          <population>the numbers analyzed differs from the Overall number analyzed because for this the Immunogenicity Evaluable Population (IEP) was used: includes all study subjects that were consented, randomized, received the assigned Treatments (both vaccinations) without significant protocol deviations and had blood drawn on Day 0, Day 21 and Day 35</population>
          <units>Geometric Mean Fold Ratios (GMFRs)</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="182"/>
                <count group_id="O2" value="173"/>
                <count group_id="O3" value="92"/>
                <count group_id="O4" value="90"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>LT IgG Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.02" lower_limit="0.95" upper_limit="1.09"/>
                    <measurement group_id="O2" value="1.04" lower_limit="0.97" upper_limit="1.12"/>
                    <measurement group_id="O3" value="0.96" lower_limit="0.89" upper_limit="1.04"/>
                    <measurement group_id="O4" value="1.02" lower_limit="0.95" upper_limit="1.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.37" lower_limit="2.01" upper_limit="2.81"/>
                    <measurement group_id="O2" value="2.73" lower_limit="2.26" upper_limit="3.31"/>
                    <measurement group_id="O3" value="0.99" lower_limit="0.92" upper_limit="1.07"/>
                    <measurement group_id="O4" value="0.98" lower_limit="0.90" upper_limit="1.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 21</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.61" lower_limit="3.76" upper_limit="5.65"/>
                    <measurement group_id="O2" value="6.03" lower_limit="4.86" upper_limit="7.47"/>
                    <measurement group_id="O3" value="1.03" lower_limit="0.94" upper_limit="1.12"/>
                    <measurement group_id="O4" value="1.17" lower_limit="1.05" upper_limit="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="180"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.91" lower_limit="7.35" upper_limit="10.81"/>
                    <measurement group_id="O2" value="11.39" lower_limit="9.33" upper_limit="13.9"/>
                    <measurement group_id="O3" value="1.31" lower_limit="1.08" upper_limit="1.58"/>
                    <measurement group_id="O4" value="1.22" lower_limit="1.08" upper_limit="1.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.90" lower_limit="8.94" upper_limit="13.29"/>
                    <measurement group_id="O2" value="14.26" lower_limit="11.74" upper_limit="17.31"/>
                    <measurement group_id="O3" value="1.32" lower_limit="1.13" upper_limit="1.53"/>
                    <measurement group_id="O4" value="1.22" lower_limit="1.08" upper_limit="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 42</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.72" lower_limit="9.67" upper_limit="14.21"/>
                    <measurement group_id="O2" value="13.65" lower_limit="11.33" upper_limit="16.44"/>
                    <measurement group_id="O3" value="1.36" lower_limit="1.11" upper_limit="1.66"/>
                    <measurement group_id="O4" value="1.24" lower_limit="1.09" upper_limit="1.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="177"/>
                    <count group_id="O2" value="167"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.34" lower_limit="9.40" upper_limit="13.68"/>
                    <measurement group_id="O2" value="13.47" lower_limit="11.26" upper_limit="16.10"/>
                    <measurement group_id="O3" value="1.36" lower_limit="1.15" upper_limit="1.60"/>
                    <measurement group_id="O4" value="1.19" lower_limit="1.05" upper_limit="1.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 90</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="161"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.18" lower_limit="9.38" upper_limit="13.32"/>
                    <measurement group_id="O2" value="11.04" lower_limit="9.28" upper_limit="13.15"/>
                    <measurement group_id="O3" value="1.23" lower_limit="1.12" upper_limit="1.36"/>
                    <measurement group_id="O4" value="1.36" lower_limit="1.20" upper_limit="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 180</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="161"/>
                    <count group_id="O2" value="154"/>
                    <count group_id="O3" value="85"/>
                    <count group_id="O4" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.49" lower_limit="5.41" upper_limit="7.79"/>
                    <measurement group_id="O2" value="6.58" lower_limit="5.58" upper_limit="7.76"/>
                    <measurement group_id="O3" value="1.15" lower_limit="1.01" upper_limit="1.30"/>
                    <measurement group_id="O4" value="1.23" lower_limit="1.09" upper_limit="1.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.02" lower_limit="0.96" upper_limit="1.08"/>
                    <measurement group_id="O2" value="0.98" lower_limit="0.93" upper_limit="1.04"/>
                    <measurement group_id="O3" value="1.00" lower_limit="0.93" upper_limit="1.06"/>
                    <measurement group_id="O4" value="1.02" lower_limit="0.97" upper_limit="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.81" lower_limit="1.59" upper_limit="2.07"/>
                    <measurement group_id="O2" value="1.99" lower_limit="1.69" upper_limit="2.34"/>
                    <measurement group_id="O3" value="0.95" lower_limit="0.88" upper_limit="1.02"/>
                    <measurement group_id="O4" value="1.00" lower_limit="0.94" upper_limit="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 21</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.52" lower_limit="2.17" upper_limit="2.93"/>
                    <measurement group_id="O2" value="2.61" lower_limit="2.20" upper_limit="3.10"/>
                    <measurement group_id="O3" value="1.04" lower_limit="0.92" upper_limit="1.19"/>
                    <measurement group_id="O4" value="1.01" lower_limit="0.93" upper_limit="1.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="180"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.03" lower_limit="3.49" upper_limit="4.65"/>
                    <measurement group_id="O2" value="4.38" lower_limit="3.72" upper_limit="5.17"/>
                    <measurement group_id="O3" value="1.07" lower_limit="0.96" upper_limit="1.20"/>
                    <measurement group_id="O4" value="1.09" lower_limit="1.00" upper_limit="1.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.91" lower_limit="3.41" upper_limit="4.48"/>
                    <measurement group_id="O2" value="4.28" lower_limit="3.63" upper_limit="5.04"/>
                    <measurement group_id="O3" value="1.11" lower_limit="0.99" upper_limit="1.24"/>
                    <measurement group_id="O4" value="1.08" lower_limit="0.98" upper_limit="1.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 42</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.41" lower_limit="2.96" upper_limit="3.92"/>
                    <measurement group_id="O2" value="3.92" lower_limit="3.34" upper_limit="4.61"/>
                    <measurement group_id="O3" value="1.07" lower_limit="0.97" upper_limit="1.19"/>
                    <measurement group_id="O4" value="1.04" lower_limit="0.93" upper_limit="1.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="177"/>
                    <count group_id="O2" value="167"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.16" lower_limit="2.76" upper_limit="3.62"/>
                    <measurement group_id="O2" value="3.53" lower_limit="3.03" upper_limit="4.11"/>
                    <measurement group_id="O3" value="1.13" lower_limit="1.01" upper_limit="1.27"/>
                    <measurement group_id="O4" value="1.13" lower_limit="1.01" upper_limit="1.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 90</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="161"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.32" lower_limit="2.03" upper_limit="2.65"/>
                    <measurement group_id="O2" value="2.58" lower_limit="2.22" upper_limit="3.0"/>
                    <measurement group_id="O3" value="0.98" lower_limit="0.92" upper_limit="1.06"/>
                    <measurement group_id="O4" value="1.02" lower_limit="0.92" upper_limit="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 180</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="161"/>
                    <count group_id="O2" value="154"/>
                    <count group_id="O3" value="85"/>
                    <count group_id="O4" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.66" lower_limit="1.46" upper_limit="1.89"/>
                    <measurement group_id="O2" value="1.89" lower_limit="1.65" upper_limit="2.16"/>
                    <measurement group_id="O3" value="0.92" lower_limit="0.83" upper_limit="1.03"/>
                    <measurement group_id="O4" value="0.90" lower_limit="0.80" upper_limit="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Seroconversion Rates</title>
        <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
        <time_frame>Day 0 to Day 180</time_frame>
        <population>the numbers analyzed differs from the Overall number analyzed because for this the Immunogenicity Evaluable Population (IEP) was used: includes all study subjects that were consented, randomized, received the assigned Treatments (both vaccinations) without significant protocol deviations and had blood drawn on Day 0, Day 21 and Day 35</population>
        <group_list>
          <group group_id="O1">
            <title>LT Patch Without Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with an LT patch (no swabbing), 37.5 mcg LT
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O2">
            <title>LT Patch With Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with an LT patch (with swabbing), 37.5 mcg LT
SPS:Buffer-prepared site swabbed with a 70% isopropyl alcohol pad
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O3">
            <title>Placebo Patch Without Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with a placebo patch (no swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
          </group>
          <group group_id="O4">
            <title>Placebo Patch With Swabbing</title>
            <description>Two vaccination (Day 0 and Day 14) regimen with a placebo patch (with swabbing)
SPS:Buffer-prepared site swabbed with a 70% isopropyl alcohol pad
Placebo: Travelers' Diarrhea Vaccine System</description>
          </group>
        </group_list>
        <measure>
          <title>Characterization and Comparison of Group LT-specific Immune Responses to the TD Vaccine System: Seroconversion Rates</title>
          <description>LT immunoglobulin G (IgG) and immunoglobulin A (IgA)</description>
          <population>the numbers analyzed differs from the Overall number analyzed because for this the Immunogenicity Evaluable Population (IEP) was used: includes all study subjects that were consented, randomized, received the assigned Treatments (both vaccinations) without significant protocol deviations and had blood drawn on Day 0, Day 21 and Day 35</population>
          <units>percentage of participants</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="182"/>
                <count group_id="O2" value="173"/>
                <count group_id="O3" value="92"/>
                <count group_id="O4" value="90"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>LT IgG Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.18" lower_limit="3.88" upper_limit="11.97"/>
                    <measurement group_id="O2" value="7.56" lower_limit="4.09" upper_limit="12.58"/>
                    <measurement group_id="O3" value="3.33" lower_limit="0.69" upper_limit="9.43"/>
                    <measurement group_id="O4" value="6.74" lower_limit="2.51" upper_limit="14.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.51" lower_limit="40.06" upper_limit="55.05"/>
                    <measurement group_id="O2" value="49.42" lower_limit="41.72" upper_limit="57.13"/>
                    <measurement group_id="O3" value="2.17" lower_limit="0.26" upper_limit="7.63"/>
                    <measurement group_id="O4" value="3.33" lower_limit="0.69" upper_limit="9.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 21</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.03" lower_limit="59.69" upper_limit="73.81"/>
                    <measurement group_id="O2" value="74.57" lower_limit="67.40" upper_limit="80.87"/>
                    <measurement group_id="O3" value="5.43" lower_limit="1.79" upper_limit="12.23"/>
                    <measurement group_id="O4" value="16.67" lower_limit="9.64" upper_limit="26.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="180"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.67" lower_limit="80.81" upper_limit="91.27"/>
                    <measurement group_id="O2" value="89.53" lower_limit="83.97" upper_limit="93.68"/>
                    <measurement group_id="O3" value="14.13" lower_limit="7.74" upper_limit="22.95"/>
                    <measurement group_id="O4" value="16.67" lower_limit="9.64" upper_limit="26.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.11" lower_limit="84.82" upper_limit="94.03"/>
                    <measurement group_id="O2" value="93.06" lower_limit="88.20" upper_limit="96.36"/>
                    <measurement group_id="O3" value="15.22" lower_limit="8.58" upper_limit="24.21"/>
                    <measurement group_id="O4" value="17.78" lower_limit="10.52" upper_limit="27.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 42</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.61" lower_limit="85.39" upper_limit="94.43"/>
                    <measurement group_id="O2" value="94.71" lower_limit="90.19" upper_limit="97.55"/>
                    <measurement group_id="O3" value="17.78" lower_limit="10.52" upper_limit="27.26"/>
                    <measurement group_id="O4" value="20.00" lower_limit="12.31" upper_limit="29.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="177"/>
                    <count group_id="O2" value="167"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.09" lower_limit="87.09" upper_limit="95.61"/>
                    <measurement group_id="O2" value="95.81" lower_limit="91.55" upper_limit="98.30"/>
                    <measurement group_id="O3" value="16.67" lower_limit="9.64" upper_limit="26.00"/>
                    <measurement group_id="O4" value="16.67" lower_limit="9.64" upper_limit="26.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 90</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="161"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.49" lower_limit="88.65" upper_limit="96.71"/>
                    <measurement group_id="O2" value="93.79" lower_limit="88.87" upper_limit="96.98"/>
                    <measurement group_id="O3" value="11.24" lower_limit="5.52" upper_limit="19.69"/>
                    <measurement group_id="O4" value="24.72" lower_limit="16.19" upper_limit="35.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgG Day 180</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="161"/>
                    <count group_id="O2" value="154"/>
                    <count group_id="O3" value="85"/>
                    <count group_id="O4" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.09" lower_limit="78.64" upper_limit="90.21"/>
                    <measurement group_id="O2" value="90.26" lower_limit="84.44" upper_limit="94.45"/>
                    <measurement group_id="O3" value="9.41" lower_limit="4.15" upper_limit="17.71"/>
                    <measurement group_id="O4" value="20.93" lower_limit="12.90" upper_limit="31.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.66" lower_limit="0.34" upper_limit="4.77"/>
                    <measurement group_id="O2" value="1.74" lower_limit="0.36" upper_limit="5.01"/>
                    <measurement group_id="O3" value="0.00" lower_limit="0.00" upper_limit="4.02"/>
                    <measurement group_id="O4" value="0.00" lower_limit="0.00" upper_limit="4.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.68" lower_limit="12.42" upper_limit="24.03"/>
                    <measurement group_id="O2" value="23.84" lower_limit="17.68" upper_limit="30.92"/>
                    <measurement group_id="O3" value="0.00" lower_limit="0.00" upper_limit="3.93"/>
                    <measurement group_id="O4" value="1.11" lower_limit="0.03" upper_limit="6.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 21</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.42" lower_limit="25.68" upper_limit="39.74"/>
                    <measurement group_id="O2" value="36.42" lower_limit="29.25" upper_limit="44.06"/>
                    <measurement group_id="O3" value="1.09" lower_limit="0.03" upper_limit="5.91"/>
                    <measurement group_id="O4" value="1.11" lower_limit="0.03" upper_limit="6.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="180"/>
                    <count group_id="O2" value="172"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.56" lower_limit="43.02" upper_limit="58.07"/>
                    <measurement group_id="O2" value="54.65" lower_limit="46.90" upper_limit="62.24"/>
                    <measurement group_id="O3" value="2.17" lower_limit="0.26" upper_limit="7.63"/>
                    <measurement group_id="O4" value="2.22" lower_limit="0.27" upper_limit="7.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 35</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="173"/>
                    <count group_id="O3" value="92"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.10" lower_limit="43.60" upper_limit="58.57"/>
                    <measurement group_id="O2" value="54.91" lower_limit="47.18" upper_limit="62.48"/>
                    <measurement group_id="O3" value="2.17" lower_limit="0.26" upper_limit="7.63"/>
                    <measurement group_id="O4" value="2.22" lower_limit="0.27" upper_limit="7.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 42</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="181"/>
                    <count group_id="O2" value="170"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.96" lower_limit="39.52" upper_limit="54.51"/>
                    <measurement group_id="O2" value="51.76" lower_limit="43.99" upper_limit="59.48"/>
                    <measurement group_id="O3" value="1.11" lower_limit="0.03" upper_limit="6.04"/>
                    <measurement group_id="O4" value="2.22" lower_limit="0.27" upper_limit="7.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 56</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="177"/>
                    <count group_id="O2" value="167"/>
                    <count group_id="O3" value="90"/>
                    <count group_id="O4" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.68" lower_limit="33.37" upper_limit="48.30"/>
                    <measurement group_id="O2" value="49.70" lower_limit="41.88" upper_limit="57.53"/>
                    <measurement group_id="O3" value="3.33" lower_limit="0.69" upper_limit="9.43"/>
                    <measurement group_id="O4" value="3.33" lower_limit="0.69" upper_limit="9.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 90</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="169"/>
                    <count group_id="O2" value="161"/>
                    <count group_id="O3" value="89"/>
                    <count group_id="O4" value="89"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.63" lower_limit="20.13" upper_limit="33.96"/>
                    <measurement group_id="O2" value="37.27" lower_limit="29.79" upper_limit="45.23"/>
                    <measurement group_id="O3" value="0.00" lower_limit="0.00" upper_limit="4.06"/>
                    <measurement group_id="O4" value="1.12" lower_limit="0.03" upper_limit="6.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>LT IgA Day 180</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="161"/>
                    <count group_id="O2" value="154"/>
                    <count group_id="O3" value="85"/>
                    <count group_id="O4" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.91" lower_limit="9.79" upper_limit="21.36"/>
                    <measurement group_id="O2" value="17.53" lower_limit="11.88" upper_limit="24.47"/>
                    <measurement group_id="O3" value="1.18" lower_limit="0.03" upper_limit="6.38"/>
                    <measurement group_id="O4" value="0.00" lower_limit="0.00" upper_limit="4.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group 1: 37.5μg LT, No Swab</title>
          <description>Two vaccination regimen with an LT patch (no swabbing)
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="E2">
          <title>Group 2: 37.5μg LT, Swab</title>
          <description>Two vaccination regimen with an LT patch (with swabbing)
Heat-Labile Enterotoxin of E. coli (LT): Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="E3">
          <title>Group 3: 0μg LT, No Swab</title>
          <description>Two vaccination regimen with a placebo patch (no swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
        </group>
        <group group_id="E4">
          <title>Group 4: 0μg LT, Swab</title>
          <description>Two vaccination regimen with a placebo patch (with swabbing)
Placebo: Travelers' Diarrhea Vaccine System</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="197" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="192" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="90" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="92" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="14" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="14" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Vaccination site erythema</sub_title>
                <counts group_id="E1" subjects_affected="164" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="157" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="32" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Vaccination site rash</sub_title>
                <counts group_id="E1" subjects_affected="173" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="168" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Vaccination site hyperpigmentation</sub_title>
                <counts group_id="E1" subjects_affected="139" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="138" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Vaccination site edema</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="73" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Vaccination site pain</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="101"/>
              </event>
              <event>
                <sub_title>Vaccination site pruritis</sub_title>
                <counts group_id="E1" subjects_affected="163" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="156" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="22" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="97"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="101"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Head Clinical Developement</name_or_title>
      <organization>Valneva Austria GmbH</organization>
      <phone>0043120620 ext 0</phone>
      <email>info@valneva.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

